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One of the important attempts in clinical oral surgery practice is to maintain 
safe and effective local anesthesia. Dental procedures are frequently performed 
under local anesthesia; thus, drug-related complications are often encountered. It is 
mandatory to have a preoperative evaluation of the patient and choosing the proper 
local anesthetic agent. Various complications including hypersensitivity, allergy, 
overdosage, toxicity, hematoma, trismus, paresthesia, or neuralgia can be observed 
during practice. Therefore, the practitioner should be aware of the possible compli-
cations and management methods. The aim of this chapter is to review the preop-
erative and postoperative complications associated with the local anesthetic in oral 
and maxillofacial surgery practice. The prevention of measures and treatment of 
the complications is also emphasized.
Keywords: local anesthesia, complication, local complications, systemic 
complications, treatment
1. Introduction
Local anesthetic agents have been used in clinical dentistry to allay or eliminate 
pain associated with invasive operations as early as the nineteenth century [1]. 
Local anesthetics are used routinely also in oral and maxillofacial surgery. Despite 
that local anesthetics are reliable and efficient drugs, the risks that practitioners 
need to be aware of were also reported [2].
Complications associated with local anesthetics can be evaluated systemically 
and locally. Common systemic reactions due to local anesthesia are reported as psy-
chogenic reactions, systemic toxicity, allergy, and methemoglobinemia. Common 
local complications associated with local anesthesia are reported as pain at injec-
tion, needle fracture, prolongation of anesthesia and various sensory disorders, lack 
of effect, trismus, infection, edema, hematoma, gingival lesions, soft tissue injury, 
and ophthalmologic complications [2, 3].
This chapter is presenting the local and systemic complications associated with 
the local anesthetics used in oral and maxillofacial surgery. The prevention of 
complications and management methods are also emphasized.
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2. Classification and chemical structure of local anesthetics
Local anesthetics can be classified according to their chemical structure, 
a rate of onset, potency, and duration of action. Chemically, they are either 
amino esters or amino amides (i.e., an aromatic, lipophilic ring connected to a 
hydrophilic amine group by an intermediate chain containing either an ester or 
amide linkage). Ester local anesthetics are hydrolyzed in the plasma by pseu-
docholinesterase into para-aminobenzoic acid (PABA) and other derivatives, 
whereas amide-type local anesthetics are metabolized by the liver. The rate of 
hydrolysis has an effect on the potential toxicity of a local anesthetic. Allergic 
reactions that occur in response to ester local anesthetics usually are related 
to para-aminobenzoic acid, which is a major metabolic product of many ester 
local anesthetics. The rates of biotransformation of amide group lidocaine, 
mepivacaine, etidocaine, and bupivacaine are similar. Articaine, which contains 
both amide and ester, metabolizes both in the liver and blood. The ester group 
(cenzoic acid esters) includes cocaine, procaine, chloroprocaine, tetracaine, and 
benzocaine. The amide group includes lidocaine, mepivacaine (Carbocaine), 
prilocaine (Citanest), bupivacaine (Marcaine), etidocaine (curanest), dibucaine 
(nupercaine), and ropivacaine (Naropin).
Ester local anesthetics are not available in dental cartridges essentially because 
of several reasons such as the lack of efficacy, the potential for allergenicity, and the 
advantages of amino amides [4–7].
3. Systemic reactions due to local anesthesia
3.1 Psychogenic reactions
This psychogenic answer is associated with either the patient’s body coun-
terbalance to an anxiety-inducing situation or due to adrenaline secreted by 
the vasoconstrictor agent. As a result of mood changes, heart rate, respiratory 
rate, and blood pressure are altered. Patients often have a blush or erythema 
which mimics allergic reactions, hyperventilation, nausea, and vomiting [3]. 
It is important to understand the patient and make them relax. In more severe 
cases, these reactions should be maintained as syncope and hyperventilation. For 
preventing psychogenic reactions, the patient should be relaxed before adminis-
tering local anesthetic injections. Using oral sedatives is an efficacious method to 
manage dental fears. Initial dosage should be dependent on patient health, age, 
weight, and duration of the operation. For healthy adult patients in short-term 
operations antihistamine-diphenhydramine (Benadryl) 50 mg 1 hour prior to 
the operation, moderate length (1–2 hours) operation benzodiazepine, triazolam 
(Halcion) 0.125–0.5 mg 1 hour before the operation triazolam, for longer duration 
(2–4 hours) benzodiazepine such as lorazepam (Ativan) 1–4 mg may be given 
1–2 hours prior to the operation or 30–60 minutes prior for the sublingual prepa-
ration may be described and given. Pharmacologically, mildly and moderately 
anxious dental patients can be managed using sedation or extremely anxious or 
phobic patients using general anesthesia [8, 9].
3.2 Systemic toxicity
Local anesthetic systemic toxicity develops when a sufficient (toxic) concentra-
tion of anesthetic drug in the blood level reaches to the central nervous system and 
cardiovascular systems.
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Initial symptoms are characterized by central nervous system signs such as 
excitation, convulsions, followed by loss of consciousness and respiratory arrest. 
These symptoms are often accompanied by cardiovascular signs such as hyperten-
sion, tachycardia, and premature ventricular contractions. The clinical signs and 
symptoms usually show objective symptoms such as quick talking, flicker, and 
tremor in the extremities [10, 11].
Predisposing factors are associated with age, weight, other drugs, gender, the 
presence of disease, genetics, vasoactivity, concentration, dose, route of adminis-
tration, the rate of injection, vascularity of the injection site, and the presence of 
vasoconstrictors [7].
In order to prevent systemic toxicity, the patient should be evaluated. The 
volume of local anesthesia should be decreased, young or lightweight patients 
should not be treated all four quadrants at one visit using local anesthetic alone; 
accurate and slow injection technique, adjustment of dosage divided administra-
tion and aspirating technique, using agents with low toxicity such as ropivacaine 
and levobupivacaine, and performing an aspiration test are recommended [11]. 
Preventing from a toxic dose complication, it should be evoked that for healthy 
adults, the suggested maximum safe dose of 2% lignocaine in 1:80,000 adrenaline 
is four-and-a-half 2 or 2.2 mL cartridges (180–198 mg lignocaine); for 3% prilo-
caine and felypressin 0.03 i.u./mL, the maximum safe dose is 400 mg (six 2 mL 
cartridges) [12]. Another strategy to reduce toxicity is using the guideline of 1/10th 
cartridge per kilo as a rough guide to the maximum dose [13].
Dentists should be aware that excessive doses of topical anesthetics while these 
agents are more concentrated to facilitate infiltration may lead to toxic effects, 
particularly in children.
Treatment at the office includes airway support, administration of 100% oxy-
gen, supine positioning, and protection from injury in the event of seizure activity, 
treating convulsions (benzodiazepines or thiopental; propofol cannot be used 
in patients with unstable blood pressure, heartbeat) [14]. If severe hypotension 
arrhythmia occurs, administration of the infusion of a 1.5 mL/kg 20% lipid emul-
sion over approximately 1 minute and then starting with continuous application 
at 0.25 mL/kg/min = 1000 mL/h). Studies have reported a resuscitation effect at a 
total dose of ≤10 mL/kg; therefore, 12 mL/kg can be used as an approximate esti-
mate for the maximum dose. The adrenaline dose should be based on resuscitation 
guidelines such as those of the American Heart Association. The American Society 
of Regional Anesthesia and Pain Medicine standard of <1 μg/kg does not need to be 
strictly adhered to [11].
3.3 Allergy
Allergy is also known as hypersensitive reactions, initiated by immunological 
mechanisms acquired through exposure to a specific allergen; re-exposure to which 
produces a heightened capacity to react. The prevalence of allergic reactions to 
amide group local anesthetics is rare. It is predicted that less than 1% of all compli-
cations are caused by an allergy. Many of the complications doubt to be allergic are 
actually anxiety-induced reactions [15].
Ester-type local anesthetics are more allergenic than amide-type local anesthet-
ics. Therefore, amide-type anesthetics are broadly used, among which lidocaine 
is the most commonly used for dental anesthesia epinephrine involving form. 
Adverse reactions to local anesthesia are caused by preservatives (e.g., methyl-p-
hydroxybenzoate), antioxidants (e.g., bisulfate), antiseptics (e.g., chlorhexidine), 
vasoconstrictor (e.g., sulfites), and other antigens such as latex, as well as local 
anesthetic drugs themselves [5].
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Allergic reactions may include mild symptoms, such as urticaria, erythema, and 
intense itching, as well as severe reactions in the form of angioedema and/or respi-
ratory distress. Even more severe life-threatening anaphylactic responses include 
symptoms of apnea, hypotension, and loss of consciousness [15].
In order to diagnose allergies, the skin prick test is the most endorsed. When 
skin prick test results are determined to be negative, intradermal testing should be 
performed for patients who have a history of allergy to local anesthetics intradermal 
tests become obligatory [15, 16].
The following treatments a local anesthetic patient had tested negative in the 
allergy tests, should be used.
The initial treatment for an allergic reaction in office at the first step should 
be the removal of the causative agent. For the management of mild symptoms, 
oral or intramuscular antihistamine-diphenhydramine (Benadryl), 25 or 50 mg, 
should be given. Additionally, hydrocortisone cream may be prescribed to relieve 
skin itching or erythema. In life-threatening cases basic life support, intramus-
cular or subcutaneous epinephrine 0.3–0.5 mg, and hospitalization services 
should be given.
Anaphylaxis is an acute potentially life-threatening hypersensitivity reaction. 
The clinical symptoms of anaphylaxis are depending on the organ systems involved. 
Uncontrolled co-existing asthma, mast cell disorders, and patients with specific 
allergens such as peanut and tree nut allergy are the risk factors for anaphylaxis. 
In emergency management of anaphylaxis in the office, due to guidelines of the 
Australasian Society of Clinical Immunology and Allergy should be in these steps, 
the patient should lie flat, but also in the case of breathing difficulty, the patient 
is allowed to sit. Adrenaline 1:1000 dilution (0.01 mg/kg up to 0.5 mg per dose) 
should be administered intramuscular with 1-mL syringes, 21 gauge needles, 
and should be repeated every 5 minutes as needed. Another recommendation 
for epinephrine is or children and adults who weigh 30 kg or over is 0.3 mg. For 
those weighing 15 to 30 kg, the epinephrine dose is 0.15 mg. The use of adrenaline 
auto-injector can also be chosen, which is carried mostly by heavy allergic patients 
themselves.
Adrenaline should be administered for anaphylaxis by intravenous (IV) route 
only in the case of profoundly hypotensive patients or patients who develop a car-
diopulmonary arrest or those who fail to respond to multiple doses of IM adrenaline 
because of the potential cardiovascular adverse effects of IV administration of 
adrenaline [17, 18].
Estelle and Simons evaluated evidence-based pharmacologic treatment of anaphy-
laxis. They agreed using epinephrine at the first step intramuscular in the treatment 
of anaphylaxis. But the use of antihistamines and glucocorticoids is controversial. 
Some authors claim using antihistamines is not effective because they are not effective 
on upper or lower airway obstruction, hypotension, or shock, while others advocate 
that these drugs decrease the side effects urticaria, flushing, headache, hypotension, 
and rhinorrhea. In the World Allergy Organization survey, glucocorticoids were 
reported to be the second most widely available medications (after epinephrine) 
for anaphylaxis treatment globally, even though some claim glucocorticoids have no 
proven benefit in anaphylaxis [19].
As a result first step of treatment must be epinephrine additionally glucocorti-
coids and antihistamines may use to treat severe systemic reactions.
3.4 Methemoglobinemia
Methemoglobinemia is a unique dose-dependent reaction where the iron in 
hemoglobin is stabilized in the ferric (Fe3+) form, unable to attach oxygen, leading 
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to tissue hypoxia and causing a varying degree of cyanosis. Methemoglobinemia 
can be either inherited or acquired [20].
The risk of methemoglobinemia increased in infants and the elderly. Patients 
with underlying health problems; liver cirrhosis, with underdeveloped hepatic 
and renal function; heart disease; and pulmonary disease (chronic obstructive 
pulmonary disease, pneumonia) are under the risk of methemoglobinemia. When 
administered in excessive doses, the local anesthetics mostly prilocaine and benzo-
caine (90% of reported cases) and barely lidocaine and articaine may also lead to 
methemoglobinemia [21].
Symptoms of cyanosis will be observed in nail beds and mucous membranes. In 
more severe cases, headache, dizziness, fatigue, dyspnea, and tachycardia are seen. 
For diagnosis in the dental clinic, pulse oximetry and in-hospital arterial blood 
analysis play an essential role [21].
Management of methemoglobinemia begins with supplemental oxygen (100%) 
immediately. As a guideline, methylene blue, which is a heterocyclic aromatic chemi-
cal compound increasing the rate of conversion of methemoglobin to hemoglobin, 
may be given to a symptomatic patient. For severe cases, hyperbaric oxygenation 
may also be used if available. Methylene blue should be administrated in 1 to 2 mg/kg 
doses, given as 0.1 mL/kg of a 1% solution (10 mg/mL) intravenously over 5–10 min-
utes every hour up to a 7 mg/kg maximum. Repeated doses may be necessary within 
30–60 minutes of the initial dose [22, 23]. Guay summarizes 242 cases of methemo-
globinemia complications related to dental local anesthetics lidocaine, bupivacaine, 
cocaine, mepivacaine, prilocaine, and tetracaine in children and adults. He concluded 
that benzocaine should be out of usage. In a specific patient group, in children 
younger than 6 months, in pregnant women, or in patients taking other oxidizing 
drugs, prilocaine should not be used. The dose should be limited to 2.5 mg/kg [21].
4. Local complications associated with local anesthesia
4.1 Pain on injection
Pain on injection can be due to specific circumstances such a temperate of the 
solution, velocity of injection, dull needles, needles with barbs, or aggressive inser-
tion of the needle, damaging soft tissues, blood vessels, nerves, or the periosteum 
and causing more pain and other complications.
The burning is dependent on the rate of injection and the acidity of the solu-
tion. Lidocaine causes an intense burning sensation when injected locally. When 
the needle penetrates a nerve, the patient may also feel a sudden “electric” shock, 
suddenly moving the head, with the risk of self-inflicted damage [24].
In order to prevent discomfort, topical anesthetic application, warming anes-
thetics to body temperature, using a smaller-gauge needle (27 gauge), switching 
to a fresh needle when you have to inject multiple times in the same lesion or when 
you have multiple injection sites, and injecting slowly and with low pressure which 
reduces pain are done. A rate of 30 seconds per mL of solution is recommended. An 
inadequate injection site can lead to an intramuscular or intraneural injection blunt-
ing of the needle, side of injection anatomic structure (palate) it is unacceptable to 
feel a little pain during injection [13, 24, 25].
4.2 Needle fracture
Needle breakage in the oral cavity after local anesthesia is a rare complication, 
since the establishment of non-reusable, stainless steel dental local anesthetic 
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needles. In most cases, needle fracture happened with 30-gauge needles and during 
inferior alveolar nerve block, as a result of either incorrect injection technique, 
improper choice of hypodermic needle magnitude, or unexpected motion of the 
patient or assistants [26].
In order to prevent needle fracture, first the injection needles should be checked; 
30-gauge and short needles should not be used for inferior alveolar nerve block in 
adults or children (25–27 should be chosen). Needles should not bend while insert-
ing them into soft tissue [26, 27].
In the case of a broken needle, if visible, it should be removed immediately 
with a hemostat. If this is inaccessible, computed tomographic (CT) scanning 
should be taken to ensure the location of the needle, and under general anes-
thesia, the patient should be operated. In the literature for the removal of the 
fragment, mostly superficial mucosal incision perpendicular to the trajectory of 
the needle followed by blunt supra-periosteal dissection to spare vital structures is 
recommended [28, 29].
Acham et al. in 2018 made an analysis of the literature complication of needle 
fracture following dental local anesthesia on 36 reports and 59 needle breakage 
events; they concluded that three-dimensional imaging techniques should be taken 
to see the broken fragment and also surrounding structures like vessels and the the 
parotid gland. It is important because 27 out of 57 cannula fragments were located 
in the pterygomandibular space, and the choice of the removal of the fragment, 
whether general or local anesthesia, should be dependent on the patient’s systemic 
condition [30].
4.3 Prolongation of anesthesia and various sensory disorders
Prolonged anesthesia, paresthesia, or neuralgia may occur following dental 
local anesthetic blocks. This may be temporary, where after a few days, weeks, or 
months, sensation returns or it may be permanent [31]. This mostly involves nervus 
lingualis or nervus mandibularis or both [32]. The nerve may be damaged during 
injection by direct injury, or the needle may damage the intraneural blood supply, 
resulting in a hematoma, or the needle may traumatize the medial pterygoid muscle 
which results in trismus. Neurotoxicity of the local anesthetic is another theory for 
nerve damage [33]. Procaine and tetracaine cause more damage than bupivacaine 
or lidocaine [34]. Paresthesia or neuralgia complication is mostly transient but may 
also be permanent if the anesthetic solution is injected directly into the nerve. Due 
to a numb feeling, the patient may have discomfort such as tongue biting, drool-
ing, loss of taste, and speech impediment. Sullivan et al. conducted a randomized, 
double-blind, placebo-controlled trial on 496 patients with Bell’s palsy. They main-
tain treatment with steroids within 3 days after onset quite advances the chance for 
full recovery at 3 or 9 months [35]. Piccinni et al. conducted an analysis of reports 
to the FDA Adverse Event Reporting System; about 573 cases of paresthesia and 
dysesthesia after local anesthetics between 2004 and 2011 were performed. They 
concluded that the use of prilocaine, articaine, or both drugs has a higher risk of 
paresthesia [36].
If a nerve is damaged due to dental local anesthesia, the first treatment should 
be managing the pain. In order to decrease local anesthesia-dependent nerve injury, 
avoiding high concentration of anesthetic agent for inferior alveolar nerve blocks 
(use 2% lidocaine as standard), preventing iterative injections, and avoiding infe-
rior alveolar nerve blocks are done by using high concentration agents (articaine) 
infiltrations only. The use of a low daily dose of multivitamin B, to regaining nerve 
healing and function, has been recommended [37, 38].
7Complications Associated with Local Anesthesia in Oral and Maxillofacial Surgery
DOI: http://dx.doi.org/10.5772/intechopen.87172
4.4 Lack of effect
Reasons for unsuccess in obtaining local anesthesia can be dependent on ana-
tomical variants, pathological and psychological factors, choice of technique and 
solution, and poor technique [24].
Anatomical factors comprise accessory nerve supply, alteration in foramen 
location, atypical development of the nerves (bifid mandibular canals), and bone 
density [39, 40].
Pathological reasons for the failure of anesthesia are trismus, infection, inflam-
mation, and previous surgery or trauma. Inflammatory diseases altering the 
pharmacokinetics and pharmacodynamics of local anesthetics cause a response to 
decrease and unfavorable effects to increase [41].
Local anesthetic failure or difficulty to obtain satisfactory analgesia commonly 
occurs in the situations with inflammations such as pulpitis and apical periodontitis 
acute periodontal abscess or pericoronitis [42]. Psychological determinants such as 
angst and anxiety can also cause local anesthesia failure [39].
Poor technique failure mostly occurs to obtain mandibular anesthesia. If the 
needle is inserted and advanced too deeply and too far dorsally, the terminal 
branches of the facial nerve within the deep lobe of the parotid gland are affected. 
Direct anesthesia to the facial nerve can force a rapid onset that occurs while the 
anesthetic agent is being injected; reflex vasospasms of the external carotid artery 
can lead to ischemia of the facial nerve, so facial nerve palsy occurs. The patient is 
unable to wrinkle the forehead, raise the eyebrow, close the upper eyelid, retract the 
commissure of the lips to smile, and turn down the lower lip on the affected side. 
The removal of contact lenses and closing of the eye on the affected side in Bell’s 
palsy prevent corneal abrasion or drying [43, 44].
In most cases, paralysis occurs immediately after mandibular anesthesia injec-
tion, but there are also some cases in which paralysis starts lately. Cakarer et al. 
have a case report for late paralyses. They extracted simple teeth, without any 
complication, and 1 day after the patient returned with complaints of a weakness 
of the muscles of the left side of his face. On the examination, they observed Bell’s 
palsy sign on the left side and unilateral expressionless, and there was no patho-
logic sign in the wound or any herpetic lesions. They consulted the patient with 
the Department of Ophthalmology and the Department of Physical Therapy and 
Rehabilitation. For the treatment lubricant eye drop (4 × 1), tobramycin ophthalmic 
solution (4 × 1) and lanolin eye ointment (during night) supported by eye patch 
were used. For 4 weeks, galvanic stimulation of the affected side of the facial nerve 
was performed, and mime therapy was recommended. In 2 weeks all of the symp-
toms disappeared [45].
If the needle is inserted too high and deep, N. auriculotemporalis will be 
affected, and the feeling of “numbness” will occur. There has been a report of sud-
den unilateral deafness following inferior dental nerve anesthesia.
4.5 Trismus
Trismus is defined as a painful circumstance with inability to open the mouth 
normally. Several factors cause trismus such as multiple injections in a short period 
of time in the same area, intramuscular injections inside the muscle or trauma to 
muscles (either the lateral pterygoid muscle or the temporal muscle) which cause 
hematoma formation and fibrosis, needle fracture in the muscles inserting to 
styloid process, inaccurate positioning of the needle when giving the inferior nerve 
block or maxillary posterior injections or inflammation of the masseter and other 
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masticatory muscles, a low-grade infection, and excessive volumes of local anes-
thetic solution deposited into a bounded region which cause expansion of tissues. In 
the acute phase, pain from hemorrhage leads to muscle contraction and limitation 
of motion.
Once trismus develops, some cases will resolve spontaneously. Progression of 
trismus to chronic hypomobility and fibrous ankylosis may be prevented by the 
early institution of treatment consisting of heat therapy; soft diet; prescription 
of analgesics, anti-inflammatory drugs, antibiotics, muscle relaxants; or physio-
therapy. Trismus caused by an infection needs to be treated by antibiotics. Usually, 
trismus will resolve in 6 weeks, with a range of 4 to 20 weeks.
Awareness of the anatomical landmarks and muscles: palpation of bony anterior 
ramus for temporalis muscle, pterygomandibular fold for pterygoid muscle, and 
appropriate angulation of the needle and bone contact before injecting are good 
methods for avoiding trismus via local anesthesia.
Intraorally the Vazirani-Akinosi technique, the closed-mouth mandibular nerve block 
technique, or extraoral techniques can provide anesthesia to trismus patients [43, 46].
4.6 Infection
Infection complication is rare since the usage of disposable needles and glass 
cartridges. Infection may extend to tissues by penetration of the needle through a 
contaminated tissue, because of the needle being contaminated before an operation 
or improper preparation of local anesthetic diluted solutions. On the other hand, a 
latent viral infection may be reactivated due to the trauma of the procedure which 
may be responsible for neural sheath inflammation.
The area to be penetrated should be cleaned with a topical antiseptic prior to 
insertion of the needle. Antiseptic mouthwash solutions such as chlorhexidine 
gluconate should be considered for all regional techniques. The local anesthesia 
should not be injected through the infected area.
Injecting local anesthesia during the presence of infection is important to increase 
the pH of anesthetic agent in order to increase efficiency because the infected tissue 
is more acidic. This process is called anesthetic buffering and leads to patient com-
fort during injection, fast onset of anesthesia, and lower postinjection tissue injury. 
Recommendation for treatment of infection is antibiotics (penicillin V 500 mg every 
6 hour for 7–10 days), analgesics, heat, drainage, and physiotherapy [2, 31, 47].
4.7 Edema
Swelling of tissues can be due to trauma during injection, infection, allergy, 
hemorrhage, and injection of irritating solutions.
The management of edema is dependent on the cause. Allergy-induced edema 
treatment consists of intramuscular epinephrine injection as mentioned above and, 
additionally, antihistamine and corticosteroid administration and consultation with 
an allergist to determine the precise cause of the edema. Trauma-induced edema 
should be managed as a hematoma. For the treatment of edema produced by infec-
tion, antibiotics should be prescribed [27].
4.8 Hematoma
Hematoma formation as a complication of local anesthesia is the result of a 
venous or arterial laceration; intra-arterial blood pressure increase causes effusion 
of blood into the surrounding soft tissues. While injecting, if there is a high pres-
sure, it may be a warning injecting against the bloodstream. The size of a hematoma 
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depends on the density and compactness of the affected tissue; when a vein rupture 
is concerned, hematoma does not necessarily occur. Discoloration on the area, a 
bruise may accompany hematoma [48].
From the anatomical point of view, different nerve effects cause hematoma on 
specific regions such as anterior superior alveolar (infraorbital) nerve block below 
the lower eyelid, incisive (mental) nerve block at the chin area, buccal nerve block 
or any palatal injection within the mouth, and posterior superior alveolar nerve 
block extraoral in the lower buccal region of the mandible, intraoral distal to maxil-
lary tuberosity.
Hematoma formation can be prevented by aspirating before injecting the 
anesthetic solution, by using a short needle and a minimum number of needle 
penetrations into tissues. When swelling forms immediately after injection, local-
ized pressure should be applied with a minimum of 2 minutes. This will stop the 
hemorrhage.
Both swelling and discoloration usually subside in 10 to 15 days. Ice packs should 
be held for the first 24 hours after surgery following which intermittent hot moist 
packs can be used to resolve the condition and massage therapy using a heparin 
cream. Antibiotics should be prescribed if the hematoma is large in order to prevent 
the development of a wound infection [14, 49].
4.9 Gingival lesions
Gingival lesions consist of recurrent aphthous stomatitis, and herpes simplex 
can occur intraorally after a local anesthetic injection or after any trauma to the 
intraoral tissues. The exact mechanism is unknown, but any trauma to tissues by 
a needle may activate the latent form of the disease process that was present in the 
tissues with previous injection.
No management is necessary until there is severe pain. In order to relieve pain, 
topical anesthetic solutions (e.g., viscous lidocaine) may be used on affected areas. 
A concoction of identical amounts of diphenhydramine and milk of magnesia 
rinsed in the mouth effectively covers the ulcerations and provides relief from pain. 
Triamcinolone acetonide without corticosteroid can remedy pain [14, 27].
4.10 Soft tissue injury
Lip or tongue biting or chewing can occur on children with special needs or 
disabled patients, following dental local anesthesia with the unfamiliar sensation of 
being numb [50]. Shorter-acting local anesthetics such as plain mepivacaine should 
be chosen, and the patient or the guardian should be warned about eating, drinking 
hot fluids, and biting on the lips or tongue to test for anesthesia; cotton rolls can be 
placed between the teeth and soft tissues to prevent chewing. In order to accelerate 
recovery time for sensation, an alpha-adrenergic receptor, phentolamine mesylate 
(OraVerse), may be injected. For adults, the proposed dosage is 1 to 2 cartridges of 
phentolamine mesylate (a dose of 0.4 to 0.8 mg), while for children the proposed 
dosage is 0.5 to 1 cartridge (0.2 to 0.4 mg) [50, 51] Malamed [52].
Swelling may decay after 2 to 3 days. The lesion will heal over the next 10 to 
14 days. For pain complains, analgesics may be prescribed and topical local anes-
thetic gel may be applied to the area.
4.11 Ophthalmologic complications
The most common complications include diplopia (dual vision), ophthalmople-
gia (paralysis or weakening of eye muscles), ptosis, and mydriasis (dilatation of 
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pupil). In extremely rare instances, amaurosis (partial/total blindness) can be seen. 
All these complications are transient and disappear on interruption of the anes-
thetic effects [53].
Intraarterial injection or perforation of the vascular wall would stimulate the 
sympathetic fibers running alongside the internal maxillary artery until reaching 
the orbit. The intravenous injection could reach the cavernous sinus via the ptery-
goid plexus and anesthetize the oculomotor, trochlear, or abducens nerves.
Horner’s syndrome may occur after an inferior dental nerve block anesthesia 
because of penetration of the local anesthetic through the lateral pharyngeal and 
prevertebral spaces, causing barrier of the stellate ganglion [54, 55].
Alamanos et al. conducted a systematic review in 2016 on ophthalmologic 
complications following dental local anesthesia with 66 reports and 89 cases. They 
found that the Gow-Gates technique for mandibular block anesthesia is only associ-
ated with diplopia, vision impairment is more associated with inferior alveolar 
nerve blocks than with posterior superior alveolar nerve blocks, and the latter 
technique has rarely been reported as a cause of amaurosis. Ocular complications in 
the literature are mostly with an injection of lidocaine [56].
In order to minimize the possible complications, visualization of the regional 
anatomy, numerous aspirations while injection, and aspiration on at least two 
planes before administration local anesthetic are performed.
5. Conclusion
Administration of a local anesthetic can be associated with complications of 
adverse events. In order to prevent local anesthetic complications, the medical 
history of the patients should routinely be evaluated in details, and effective anxiety 
management should be performed. Doses of local anesthetics should be always 
strictly assessed with body weight, and the maximum recommended dosages 
should be considered. While administrating anesthesia, the painless injection 
should be performed, avoiding intravascular or intramuscular or direct trauma to 
the nerve. New developments should be followed by the practitioners to reduce 
possible complications associated with the local anesthesia.
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